Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Recruiting
N/A
Interventional Study
Hypertension
Cardiovascular Diseases (CVD)
Inflammation
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 34 (estimated)
- Sponsor
- Universidade Federal Fluminense · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of stage 1 hypertension
* Regular treatment for more than 6 months
* No changes in medication doses during the last 3 months
Exclusion Criteria:
* Autoimmune diseases
* Infectious diseases
* Diabetes
* Chronic kidney disease
* Liver disease
* Cancer
* AIDS
* Pregna…
Contacts